Pulmonary & Internal Medicine is categorized under Health Services in Encinitas, CA and active since 2009.
Pulmonary & Internal Medicine was established in 2009, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Health Services business, which does work in the B2C market, and is classified as a Health Services, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact William J Ackerman at the company’s single location by writing to 1200 Garden View Road # 200, Encinitas, California CA 92024 or by phoning (760) 944-0223. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Pulmonary & Internal Medicine |
| Contact Person: | William J Ackerman |
| Address: | 1200 Garden View Road # 200, Encinitas, California 92024 |
| Phone Number: | (760) 944-0223 |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Founded: | 2009 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Health Services |
| SIC Code: | 8099 |
| NAICS Code: | 6211110 |
| Share This Business: |
Pulmonary & Internal Medicine was started in 2009 to provide professional Health Services under the SIC code 8099 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact William J Ackerman for inquiries that concern Pulmonary & Internal Medicine by calling the company number (760) 944-0223, as your correspondence is most welcome. Additionally, the physical location of the single location of Pulmonary & Internal Medicine can be found at the coordinates 33.05838,-117.26042 as well as the street address 1200 Garden View Road # 200 in Encinitas, California 92024.
For its online presence, you may visit Pulmonary & Internal Medicine’s website at and engage with its social media outlets through on Twitter and on Facebook.